Improving The Principles Of Treatment In Patients With Zoonotic Leishmaniasis With The Immunomodulator Gepon And Methylene Blue Using The Alt Vostok Apparatus
Keywords:
Abstract
The object of the study was 102 patients with zoonotic leishmaniasis aged 2 to 65 years. The diagnosis of zoonotic leishmaniasis was established by clinical and epidemiological data and confirmed by the results of parasitological studies.
We studied the duration of the clinical periods of zoonotic leishmaniasis against the background of complex therapy with methylene blue using the ALT Vostok apparatus in the control group of 51 patients and complex therapy with methylene blue using the ALT Vostok apparatus and the immunomodulator Gepon in the main group of 51 patients. The results of the study showed that in patients of the main group, on the background of treatment with the ALT Vostok apparatus using the immunomodulator Gepon, the duration of the main periods was significantly reduced than in the control group, who were treated only with methylene blue using the ALT Vostok model-03 apparatus.
Similar Articles
-
Clinical And Morphological Features And Histological Variants Of Borderline Types Of Ovarian Tumors
The American Journal of Medical Sciences and Pharmaceutical Research: No. 01 (2021) / Yakubbekova Sokhibakhon Sadiqovna , Israilov Rejab Israilovich , Mamarasulova Dilfuzaxon Zakirjanovna , Azizov Yuriy Daliyevich , Inaqova Zebo Tahirovna, -
Glial Tumors Of The Brain, With Associated Hydrocephalia
The American Journal of Medical Sciences and Pharmaceutical Research: No. 10 (2020) / Ruzikulov M.M., Mukhammedaminov B.Sh., Rahimov I.I., Burnashev M.I., Kim A.A., -
Clinical, Immunological And Molecular-Genetic Characteristic Of Aggressive Pituitary Adenomas
The American Journal of Medical Sciences and Pharmaceutical Research: No. 04 (2021) / Khalimova Zamira Yusufovna, Azimova Ozoda Tal`Atovna, -
Diabetic Retinopathy In Patients With Type 2 Diabetes: Aspects Of Early Diagnosis, Treatment And Prediction Of The Outcome Of The Disease
The American Journal of Medical Sciences and Pharmaceutical Research: No. 7 (2021) / Fazilat Arifovna Bakhritdinova, Urmanova Firuza Makhkamovna, Nabiyeva Iroda Fayzullayevna, -
Clinical Characteristics Of Patients With Clear Cell Ovarian Cancer And Mixed Malignant Epithelial Ovarian Tumors
The American Journal of Medical Sciences and Pharmaceutical Research: No. 01 (2021) / Dilfuzahon Mamarasulova , Bakhtiyorjon Matkarimov, Ziyoda Kamilova , -
Epidemiology, Risk Factors, Clinical-Imaging Features And Priorities For The Prevention Of Esophageal Cancer In The Fergana Valley Of Uzbekistan
The American Journal of Medical Sciences and Pharmaceutical Research: No. 01 (2021) / Azizbek Zulunov , Dilfuzahon Mamarasulova , Nematjon Mamasaliev, -
Influence Of Different Hypoglycemic Therapy Schemes On Carbohydrate Exchange Indicators In Type 2 Diabetes Mellitus
The American Journal of Medical Sciences and Pharmaceutical Research: No. 06 (2021) / S.I. Ismailov , S.U. Muminova, -
Genetic Determinism Of Chronic Kidney Disease By Ace Gene In Children And Adolescents Of The Uzbek Population With Type 1 Diabetes According To The K/Doqi Recommendation (2012)
The American Journal of Medical Sciences and Pharmaceutical Research: No. 06 (2021) / Rakhimova G.N., Sadikova A.S., -
Management Of A Patient With A Rare Variant Of Autoimmune Polyglandular Syndrome Of The Second Type
The American Journal of Medical Sciences and Pharmaceutical Research: No. 07 (2020) / Negmatova Gulzoda Shuhratovna, -
Management Of A Patient With A Rare Variant Of Autoimmune Polyglandular Syndrome Of The Second Type
The American Journal of Medical Sciences and Pharmaceutical Research: No. 07 (2020) / Negmatova Gulzoda Shuhratovna,
References
Weekly epidemiological record of WHO 2018.
Dzhalilova N.A., 2014.
Dudchenko M.I. et al., 2002.
HIV peptides.1998. Rupert, H.
Silin D.S., Lyubomskaya O.V., Ershov, F.I., Frolov V.M., Kutsyna, 2009.
Khaitov R.M., Pinegin B.V., 2001.
Ataullakhanov R.I., Holmes R.D., Narovlyansky A.N. et al., 2002.
